Press "Enter" to skip to content

Aytu Biopharma Files Form 10-K Annual Report with SEC

Aytu Biopharma Files Annual Report Form 10-K with SEC on October 12, 2023 for fiscal year ending June 30, 2023. Aytu Biopharma is exploring use of ultraviolet disinfection with Healight esophogeal explorative device. Full text of Form 10-K available at: https://tinyurl.com/ynmtsm4r COMPANY OVERVIEW Aytu BioPharma, Inc. (“Aytu,” the “Company”, “we”) is a pharmaceutical company focused…

This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.